Keyphrases
Cost-effectiveness Analysis
100%
Uganda
100%
Diagnostic Test
100%
Malaria Diagnosis
100%
Drug Shops
100%
Cluster Randomized Trial
100%
Artemisinin-based Combination Therapy
60%
Malaria
50%
Presumptive Diagnosis
30%
Health Sector
20%
Household Costs
10%
Treatment Costs
10%
Malaria Incidence
10%
Fever
10%
Malaria Treatment
10%
Parasitological
10%
Incremental Cost
10%
Selling
10%
Correct Diagnosis
10%
Ugandan
10%
Randomized Trial
10%
Sensitivity Analysis
10%
Community Sensitisation
10%
Treatment Seeking
10%
Africa
10%
Low Adherence
10%
Mukono
10%
Limited Training Data
10%
Control Arm
10%
Rapid Diagnostic Test
10%
Societal Costs
10%
Malaria Patients
10%
Medicine and Dentistry
Health Care Cost
100%
Cluster Randomized Trial
100%
Cost-Effectiveness Analysis
100%
Diagnostic Testing
100%
Artemisinin
85%
Combination Therapy
71%
Household
42%
Arm
28%
Sensitization
14%
Prevalence
14%
Rapid Diagnostic Test
14%
Biochemistry, Genetics and Molecular Biology
Drug Therapy
100%
Prevalence
100%
Sensitization
100%
Cluster Randomized Trial
100%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Cluster Randomized Trial
100%
Artemisinin
100%
Prevalence
16%
Pharmacotherapy
16%
Immunology and Microbiology
Arm
100%
Prevalence
50%
Sensitization
50%
Drug Therapy
50%
Neuroscience
Artemisinin
100%
Drug Therapy
16%